Document:

<PAGE>

                                                                    EXHIBIT 10.3

                            SCIENTIFIC ADVISORY BOARD

                              CONSULTING AGREEMENT

      This Agreement is made as of this __th day of ____________, 2004, between
Nanosys, Inc., a Delaware corporation (the "Company"), and ___________________
(the "Consultant") and shall be effective upon execution by the Consultant (the
"Effective Date").

      The Consultant has been involved in scientific research in fields of
particular interest to the Company. The Company wishes to retain the Consultant
in a consulting capacity and as a member of the Company's Scientific Advisory
Board and the Consultant desires to perform such consulting services.
Accordingly, the parties agree as follows:

      1. Services.

            1.1 The Consultant will advise the Company's management, employees
and agents, at reasonable times, in matters related to the relevant field of
interest, as requested by the Company and set forth in Exhibit A attached
hereto. The field of interest for consulting hereunder involves the field of
nanotechnology as set forth in Exhibit B (the "Field of Interest").

            1.2 Consultant will provide up to ten (10) full days (or full days
equivalents; a full day equivalent is seven (7) working hours) of consulting per
year (such days are referred to below as "Consulting Days"). Consultation may be
sought by the Company over the telephone, in person at the Consultant's office,
at the Company's offices or another reasonable location or through written
correspondence, and will involve reviewing activities and developments in the
Field of Interest. If the Company requests additional consulting days, the
Consultant will be paid a fee for each additional day as set forth below.

      2. Cash Compensation. The Consultant will be paid a per diem fee of
$_______ to be paid quarterly, plus an additional fee of $_______ for each
additional full day of consulting services above the maximum annual number of
days set forth above. A detailed accounting of Consulting Days, including date,
time and service provided, should be forwarded to the Company on a quarterly
basis. Payment will be made at the per diem rate as defined above for all
Consulting Days provided during that quarter. Reasonable expenses of the
Consultant incurred at the request of the Company (including travel expenses
incurred in connection with Company related business in accordance with the
Company's travel policy) will be reimbursed promptly by the Company, subject to
customary verification.

      3. Term. The term of this Agreement will begin on the Effective Date of
this Agreement and will end on the first anniversary of this Agreement or upon
earlier termination as provided
<PAGE>
below (the "Term"); provided that the Term may be renewed for successive
one-year periods. This Agreement may be terminated at any time upon written
notice by either party.

      4. Equity. Consultant will be permitted to purchase up to ___________
(X,XXX) shares of the Company's Common Stock at a price per share equal to the
fair market value per share of the Company's Common Stock on the date of grant,
as determined by the Company's Board of Directors. Grant date is typically at
the Company's next regularly schedule Board of Directors' meeting. One sixtieth
(1/60) of the Shares shall be released on the corresponding day of each month
thereafter, for a period of sixty (60) months, provided that the Consultant
continues to render services to the Company on those dates. The purchase of
Common Stock will be subject to the terms and conditions of the Company's
standard form of Restricted Stock Purchase Agreement and standard form of
Co-Sale Agreement.

      5. Certain Other Contracts.

            5.1 The Consultant is currently employed by an academic or research
institution (the "Institution"). The Company recognizes that the Consultant's
primary responsibility is to the Institution. In connection with such
employment, the Consultant has entered into certain agreements with the
Institution relating to ownership of intellectual property rights, conflicts of
interest and other matters, and is subject to certain policy statements of the
Institution (collectively, the "Institutional Agreement"). If any provision of
this Agreement is in conflict with the Institutional Agreement, then the
Institutional Agreement will govern to the extent of such conflict, and the
conflicting provisions of this Agreement will not apply. Consultant agrees to
furnish the Company with copies of such agreements and policy statements.

            5.2 The Consultant will not disclose to the Company any information
that the Consultant is obligated to keep secret pursuant to an existing
confidentiality agreement with a third party, and nothing in this Agreement will
impose any obligation on the Consultant to the contrary.

            5.3 The consulting work performed hereunder will not be conducted on
time that is required to be devoted to the Institution or any other third party.
The Consultant shall not use the funding, resources and facilities of the
Institution or any other third party to perform consulting work hereunder and
shall not perform the consulting work hereunder in any manner that would give
the Institution or any third party rights to the product of such work. Nothing
done in Consultant's academic research shall be considered part of services
performed hereunder and nothing herein shall restrict Consultant's academic
research.

            5.4 The Consultant has disclosed and, during the Term, will disclose
to the President of the Company any conflicts between this Agreement and any
other agreements binding the Consultant.

      6. Exclusive Services During the Term. Subject to written waivers that may
be provided by the Company upon request, which shall not be unreasonably
withheld, the Consultant agrees that during the Term of this Agreement he will
not directly or indirectly (i) provide any services in the Field of Interest to
any other business or commercial entity, (ii) participate in the formation of
any business or commercial entity in the Field of Interest, or (iii) solicit or
hire away any employee or consultant of the Company during the Term and for
twelve (12) months thereafter. The Consultant has disclosed his relationships
with the companies listed on Exhibit C attached hereto

                                      -2-
<PAGE>
and the foregoing will not apply to such relationships as disclosed on Exhibit
C. Consultant shall notify the Company of all other consulting agreements which
Consultant has entered into, or any consulting services which Consultant may
provide, to any third party.

      7. Direction of Projects and Inventions to the Company. Subject to the
Consultant's obligations under the Institutional Agreement and confidentiality
obligations to third parties, during the Term of this Agreement, the Consultant
will use his best efforts (i) to disclose to the President of the Company, on a
confidential basis, technology and product opportunities which come to the
attention of the Consultant in the Field of Interest, and any invention,
improvement, discovery, process, formula or method or other intellectual
property relating to or useful in, the Field of Interest (collectively "New
Discoveries"), whether or not patentable or copyrightable, and whether or not
discovered or developed by Consultant, and (ii) with regard to any New
Discoveries discovered or developed by Consultant at the Institution, to solicit
and encourage the Institution to enter into an agreement with the Company to
exclusively license such New Discovery to the Company.

      8. Inventions Discovered by the Consultant While Performing Services
Hereunder. The Consultant will promptly and fully disclose to the President of
the Company any invention, improvement, discovery, process, formula, technique,
method, trade secret, or other intellectual property, whether or not patentable,
whether or not copyrightable (collectively, "Invention") made, conceived,
developed, or first reduced to practice by the Consultant, either alone or
jointly with others, while performing services hereunder. The Consultant hereby
assigns to the Company all of his right, title and interest in and to any such
Inventions. The Consultant will execute any documents necessary to perfect the
assignment of such Inventions to the Company and to enable the Company to apply
for, obtain, and enforce patents or copyrights in any and all countries on such
Inventions. The Consultant hereby irrevocably designates the Secretary of the
Company as his agent and attorney-in-fact to execute and file any such document
and to do all lawful acts necessary to apply for and obtain patents and
copyrights, and to enforce the Company's rights under this paragraph. This
Section 8 will survive the termination of this Agreement.

      9. Confidentiality.

            9.1 The Consultant acknowledges that, during the course of
performing his services hereunder, the Company will be disclosing information to
the Consultant, and the Consultant will be developing information related to the
Field of Interest, Inventions, projects, products, potential customers,
personnel, business plans, and finances, as well as other commercially valuable
information (collectively "Confidential Information"). The Consultant
acknowledges that the Company's business is extremely competitive, dependent in
part upon the maintenance of secrecy, and that any disclosure of the
Confidential Information would result in serious harm to the Company.

            9.2 The Consultant agrees that the Confidential Information will be
used by the Consultant only in connection with consulting activities hereunder,
and will not be used in any way that is detrimental to the Company.

            9.3 The Consultant agrees not to disclose, directly or indirectly,
the Confidential Information to any third person or entity, other than
representatives or agents of the Company. The Consultant will treat all such
information as confidential and proprietary property of the Company.

                                      -3-
<PAGE>
            9.4 The term "Confidential Information" does not include information
that (i) is or becomes generally available to the public other than by
disclosure in violation of this Agreement, (ii) was within the relevant party's
possession prior to being furnished to such party, (iii) becomes available to
the relevant party on a non-confidential basis, or (iv) was independently
developed by the relevant party without reference to the information provided by
the Company.

            9.5 The Consultant may disclose any Confidential Information that is
required to be disclosed by law, government regulation or court order. If
disclosure is required, the Consultant will give the Company advance notice so
that the Company may seek a protective order or take other action reasonable in
light of the circumstances.

            9.6 Upon termination of this Agreement, the Consultant will promptly
return to the Company all materials containing Confidential Information as well
as data, records, reports and other property, furnished by the Company to the
Consultant or produced by the Consultant in connection with services rendered
hereunder, together with all copies of any of the foregoing. Notwithstanding
such return, the Consultant shall continue to be bound by the terms of the
confidentiality provisions contained in this Section 9 for a period of three
years after the termination of this Agreement.

      10. Freedom to Publish.

            10.1 The Company acknowledges the Consultant's obligation to
disseminate new knowledge and research findings. Notwithstanding the
confidentiality provisions, or any other provision, of this Agreement, the
Consultant may publish and make oral presentations of the results of the
Consultant's work performed pursuant to this Agreement under the terms set forth
in this Section 10.

            10.2 The Consultant acknowledges that publication or oral disclosure
of any Invention or other work prior to filing for patent or copyright
protection could result in the complete loss of any commercial value of the
Consultant's research to the Institution, the Company, and/or the Consultant, as
the case may be. The Consultant will provide the Company with sufficient
disclosure regarding Inventions owned by the Company under Section 8 at least 90
days prior to publication to allow the Company to evaluate such disclosure;
Consultant will work with the Institution (and the Company if appropriate) to
file patent or copyright applications prior to disclosure or publication, or to
modify such publication if such disclosure regarding Inventions owned by the
Company under Section 8 would materially affect the business of the Company.

      11. Use of Name. It is understood that the name of the Consultant and
Consultant's affiliation with the Institution will appear in disclosure
documents required by securities laws, and in other regulatory and
administrative filings in the ordinary course of the Company's business. The
above described uses will be deemed to be non-commercial uses. The name of the
Consultant or the Institution will not be used for any commercial purpose
without the Consultant's consent.

      12. No Conflict: Valid and Binding. The Consultant represents that neither
the execution of this Agreement nor the performance of the Consultant's
obligations under this Agreement (as modified to the extent required by Section
5) will result in a violation or breach of any other agreement by which the
Consultant is bound. The Company represents that this Agreement has

                                      -4-
<PAGE>
been duly authorized and executed and is a valid and legally binding obligation
of the Company, subject to no conflicting agreements.

      13. Notices. Any notice provided under this Agreement shall be in writing
and shall be deemed to have been effectively given (i) upon receipt when
delivered personally, (ii) one day after sending when sent by private express
mail service (such as Federal Express), or (iii) 5 days after sending when sent
by regular mail to the following address:

           In the case of the Company:

           Nanosys, Inc
           2625 Hanover St
           Palo Alto, Ca  94304
           Attn: Calvin Chow

           In the case of the Consultant:

           ------------------
           ------------------
           ------------------
           ------------------
           ------------------

or to other such address as may have been designated by the Company or the
Consultant by notice to the other given as provided herein.

      14. Independent Contractor: Withholding. The Consultant will at all times
be an independent contractor, and as such will not have authority to bind the
Company. Consultant will not act as an agent nor shall he be deemed to be an
employee of the Company for the purposes of any employee benefit program,
unemployment benefits, or otherwise. The Consultant recognizes that no amount
will be withheld from his compensation for payment of any federal, state, or
local taxes and that the Consultant has sole responsibility to pay such taxes,
if any, and file such returns as shall be required by applicable laws and
regulations. Consultant shall not enter into any agreements or incur any
obligations on behalf of the Company.

      15. Assignment. Due to the personal nature of the services to be rendered
by the Consultant, the Consultant may not assign this Agreement. The Company may
assign all rights and liabilities under this Agreement to a subsidiary or an
affiliate or to a successor to all or a substantial part of its business and
assets without the consent of the Consultant. Subject to the foregoing, this
Agreement will inure to the benefit of and be binding upon each of the heirs,
assigns and successors of the respective parties.

      16. Severability. If any provision of this Agreement shall be declared
invalid, illegal or unenforceable, such provision shall be severed and the
remaining provisions shall continue in full force and effect.

                                      -5-
<PAGE>
      17. Remedies. The Consultant acknowledges that the Company would have no
adequate remedy at law to enforce Sections 6, 8 and 9 hereof. In the event of a
violation by the Consultant of such Sections, the Company shall have the right
to obtain injunctive or other similar relief, as well as any other relevant
damages, without the requirement of posting bond or other similar measures.

      18. Governing Law; Entire Agreement; Amendment. This Agreement shall be
governed by the laws of the Commonwealth of Massachusetts applicable to
agreements made and to be performed within such State, represents the entire
understanding of the parties, supersedes all prior agreements between the
parties, and may only be amended in writing.

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first written above.

COMPANY:                                    CONSULTANT:

NANOSYS, INC.

By:                                         By:
    ------------------------------------        --------------------------------

Name:                                       Name:
     -----------------------------------         -------------------------------

Title:                                      Title:
      ----------------------------------           -----------------------------

                                      -6-
<PAGE>
                                    EXHIBIT A

                             Description of Services

      Assist the management of the Company by:

1)    Determining the general scientific direction of the company;

2)    Recruiting of Scientific Advisory Board Members and Consultants to the
Company;

3)    Recruiting full-time management and scientific personnel to the Company;

4)    Reviewing the goals of the Company and developing strategies for achieving
them;

5)    Identifying and developing relationships with potential strategic
partners;

6)    Interacting with potential investors, stockholders, and strategic or
corporate partners;

7)    Identifying and reviewing promising scientific developments and
intellectual property;

8)    Providing advice, support, theories, techniques and improvements in the
Company's scientific research and product development activities.
<PAGE>
                                    EXHIBIT B

                           EXCLUSIVE FIELD OF INTEREST

    The Advisor will provide exclusive consulting services to the Company in
    one or more of the following fields:

1)    Strategies for the design, synthesis characterization and assembly of zero
      and one dimensional nanostructures (e.g., colloids, nanocrystals (quantum
      dots), nanowires, other objects with at least one physical dimensions that
      is less than 100 nm);

2)    Strategies for the design, synthesis, characterization and assembly of
      zero and one dimensional nanostructures with unique physical properties
      (e.g., electronic, optical, mechanical, magnetic);

3)    Strategies for the hierarchical assembly of zero and one dimensional
      nanostructures into complex devices;

4)    Applications of nanostructure enabled devices in chemical and biological
      sensing, optoelectronics, microelectronics and nanoelectronics, and
      closely related areas.
<PAGE>
                                    EXHIBIT C

                               Other Relationships<PAGE>
                                                                 EXHIBIT 10.15.2

[NANOSYS LETTERHEAD]          2625 Hanover Street, Palo Alto, CA 94304
                              650.331.2100, 650.331.2101 fax, www.nanosysinc.com

May 17, 2004

Dr. James Romine
Director
DuPont Materials Science & Engineering
Experimental Station 328/407
Wilmington, DE 19880-0328

     Re: DuPont/Nanosys Collaboration Agreement

Dear Jim:

The following represents our understanding of the status of our agreement with
DuPont (the "Agreement"):

Pursuant to section 10.2, of the Agreement, the Agreement is scheduled to
terminate three months after the Commencement Date of the Agreement, which, as
amended in Amendment A to the Agreement, is May 17th, 2004, unless the Parties
have agreed in writing to continue the collaboration under the Agreement.

At present, both Parties hereby agree to continue the Collaboration under the
Agreement. As a next step, the Parties will work expeditiously together to
formulate mutually acceptable Statements of Work, based on the learnings to
date. These Statements of Work will provide the sole basis for determining the
appropriate timing and level of ongoing funding for future tasks.

Please indicate DuPont's agreement by signing and returning this letter to my
attention via facsimile at (650) 331-2101.

Please feel free to call me if you have any questions.

Sincerely,

/s/ CALVIN CHOW
---------------
Calvin Chow
CEO, Nanosys, Inc.

Accepted and agreed:

By:     /s/ JAMES C. ROMINE
        -------------------
Name:   James C. Romine
        -------------------
Title:  Science Director
        -------------------
Date:   5/20/04
        -------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}]]